93 related articles for article (PubMed ID: 10366470)
41. Versican expression in human cervical cancer.
Kodama J; Hasengaowa ; Kusumoto T; Seki N; Matsuo T; Nakamura K; Hongo A; Hiramatsu Y
Eur J Cancer; 2007 Jun; 43(9):1460-6. PubMed ID: 17446061
[TBL] [Abstract][Full Text] [Related]
42. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.
Atula T; Hedström J; Finne P; Leivo I; Markkanen-Leppänen M; Haglund C
Anticancer Res; 2003; 23(3C):3051-6. PubMed ID: 12926160
[TBL] [Abstract][Full Text] [Related]
43. Vimentin expression in cervical carcinomas: association with invasive and migratory potential.
Gilles C; Polette M; Piette J; Delvigne AC; Thompson EW; Foidart JM; Birembaut P
J Pathol; 1996 Oct; 180(2):175-80. PubMed ID: 8976877
[TBL] [Abstract][Full Text] [Related]
44. [Relationship of an extracellular matrix protein, tenascin and breast diseases].
Ishihara A; Yatani R; Sakakura T
Rinsho Byori; 1993 Oct; 41(10):1099-107. PubMed ID: 7504753
[TBL] [Abstract][Full Text] [Related]
45. Can tenascin be redundant in cancer development?
Sakakura T; Kusakabe M
Perspect Dev Neurobiol; 1994; 2(1):111-16. PubMed ID: 7530137
[TBL] [Abstract][Full Text] [Related]
46. Intracellular localization of tenascin in squamous cell carcinoma of oral cavity: an immunohistochemical study.
Mori M; Muramatsu Y; Yamada K; Shrestha P; Takai Y
Anticancer Res; 1996; 16(5B):3075-9. PubMed ID: 8920770
[TBL] [Abstract][Full Text] [Related]
47. [Expression of extracellular matrix glycoprotein tenascin in the laryngeal cancer].
Zhang S; Liu Q; Liu Z; Hua X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Dec; 16(12):643-5. PubMed ID: 12669429
[TBL] [Abstract][Full Text] [Related]
48. Tenascin expression in elastotic cuffs of invasive ductal carcinoma of the breast.
Melis M; Baiocchini A; Soda G; Bosco D
Pathol Res Pract; 1997; 193(7):479-84. PubMed ID: 9342753
[TBL] [Abstract][Full Text] [Related]
49. Association of syndecan-1 with angiogenesis-related markers, extracellular matrix components, and clinicopathological features in colorectal carcinoma.
Mitselou A; Skoufi U; Tsimogiannis KE; Briasoulis E; Vougiouklakis T; Arvanitis D; Ioachim E
Anticancer Res; 2012 Sep; 32(9):3977-85. PubMed ID: 22993347
[TBL] [Abstract][Full Text] [Related]
50. Tenascin expression in adenoid basal cell carcinoma of the skin.
Saitoh M; Yamada T; Shrestha P; Yamada K; Tsujimura T; Mori M
Anticancer Res; 1996; 16(1):129-34. PubMed ID: 8615597
[TBL] [Abstract][Full Text] [Related]
51. Tenascin expression and postnatal development of the human prostate.
Shiraishi T; Kato H; Komada S; Imai H; Hirokawa Y; Kusano I; Yatani R; Sakakura T
Int J Dev Biol; 1994 Jun; 38(2):391-5. PubMed ID: 7526883
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes.
Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
Br J Cancer; 1995 Jul; 72(1):189-92. PubMed ID: 7541237
[TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical studies on tenascin in human yellow ligament.
Fujii Y; Yoshida H; Sakou T
In Vivo; 1993; 7(2):143-6. PubMed ID: 7689866
[TBL] [Abstract][Full Text] [Related]
54. Tenascin in inflammatory conditions and neoplasms of the urinary bladder.
Tiitta O; Wahlström T; Virtanen I; Gould VE
Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 63(5):283-7. PubMed ID: 7685960
[TBL] [Abstract][Full Text] [Related]
55. Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma.
Ibrahim SN; Lightner VA; Ventimiglia JB; Ibrahim GK; Walther PJ; Bigner DD; Humphrey PA
Hum Pathol; 1993 Sep; 24(9):982-9. PubMed ID: 7504654
[TBL] [Abstract][Full Text] [Related]
56. Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas.
Regezi JA; Ramos DM; Pytela R; Dekker NP; Jordan RC
Oral Oncol; 2002 Jun; 38(4):332-6. PubMed ID: 12076695
[TBL] [Abstract][Full Text] [Related]
57. MR targeted imaging for the expression of tenascin-C in cervical cancer.
Song J; Hu Q; Huang J; Chen T; Ma Z; Shi H
Br J Radiol; 2018 Oct; 91(1090):20170681. PubMed ID: 29987979
[TBL] [Abstract][Full Text] [Related]
58. Tenascin-C expression correlates with prognosis in gastric cancer.
Wiksten JP; Lundin J; Nordling S; Lundin M; Kokkola A; von Boguslawski K; Haglund C
Oncology; 2003; 64(3):245-50. PubMed ID: 12697965
[TBL] [Abstract][Full Text] [Related]
59. Collagen IV and tenascin immunoreactivity as prognostic determinant in benign and malignant salivary gland tumours.
Kärjä V; Syrjänen K; Syrjänen S
Acta Otolaryngol; 1995 Jul; 115(4):569-75. PubMed ID: 7572138
[TBL] [Abstract][Full Text] [Related]
60. Tenascin immunoreactivity in lung tumors.
Soini Y; Pääkkö P; Nuorva K; Kamel D; Linnala A; Virtanen I; Lehto VP
Am J Clin Pathol; 1993 Aug; 100(2):145-50. PubMed ID: 7689293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
